Immatics is a startup based in Germany.
Immatics is a biotechnology company developing T-cell receptor (TCR)-based cellular therapies and cancer vaccines that target tumor-specific antigens to treat various cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.